Dr. Matthew Eisenberg, assistant professor in the Johns Hopkins Bloomberg School of Public Heath’s department of health policy and management, and Dr. Colleen Barry, the Fred and Julie Soper professor and chair of the department, were recently awarded a $1.8 million four-year grant from the National Institute on Drug Abuse.
The grant will support research that analyzes the impact of consumer-directed health plans – those with high-deductibles paired with tax-advantaged savings accounts – relative to traditional, low-deductible health plans on utilization of substance use disorder (SUD) treatment. The investigators will examine how consumer-directed health plans affect access to medication treatment for opioid use disorder (OUD). They will also examine access to services for conditions that commonly co-occur with SUD, including treatment for diabetes, cardiovascular disease, depression and nicotine dependence.
Dr. Eisenberg is an applied micro-economist whose research uses administrative and survey data to examine the utilization and spending implications of the broad, national, shift towards consumer-oriented health care. Dr. Barry is a health policy researcher and a national expert in the delivery and financing of SUD and mental health services with over 15 years of experience studying the effects of insurance design on behavioral health outcomes.